TOP NEWS

Science37 Seeks $130M More For Clinical Trial Technology, Says Report

Playa Vista-based Science37, which develops technology to allow pharmaceutical companies to conduct clinical trials at patients' homes, is reportedly raising around $130M in a funding round from Softbank, according to a report this morning. The round, a Series D, appears to value to company at around $300M. Science37 has previously raised $67M in funding from such backers as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures.